S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Lay Description
The purpose of this study is to understand the types of oral cancer pain patients experience in order to develop new treatments to alleviate this pain. This study will evaluate the types of pain and how much pain oral cancer patients experience before they receive treatment of their cancer.
Category
- Cancers and Other Neoplasms
- Mouth and Tooth
- IRB Number
- 20110197HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Regulatory Point of Contact
Cara Gonzales
(210) 567-3332
gonzalesc5@uthscsa.edu
Regulatory Point of Contact
Carolyn Whitehead
(210) 567-3452
whitehead@uthscsa.edu
Local Recruitment Point of Contact
Cara Gonzales
(210) 567-3332
gonzalesc5@uthscsa.edu
Local Recruitment Point of Contact
Carolyn Whitehead
(210) 567-3452
whitehead@uthscsa.edu
Principal Investigator
Cara Gonzales